← Leaderboards
Christopher Degiorgio
Neurosigma, Inc.
$723,319
Attributed
$723,319
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $418.3K · FY2011–13$500K$375K$250K$125K$0
'11
'12
'13
Funding mix
By agency
NIH$723,319 · 2
By mechanism
R41$418,261 · 1
U44$305,058 · 1
Top collaborators
No co-investigators on record.
Most similar at Neurosigma, Inc.
Same institution · by research overlap
- Colin Patrick Kealey$2,879,506
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAffectAmericanAnimal DataAntiepileptic AgentsBrainCerebral CortexCessation Of LifeChronicClinical TrialsCommercializationCostCranial NervesCutaneousDeep Brain StimulationDesignDevicesDrug ResistanceElectrodesEngineering DesignEnsureEpilepsyFaceAdverse Drug Effect